The Role of the cGAS–STING Pathway in Polycystic Ovary Syndrome: A Systematic Review of Molecular Mechanisms and Therapeutic Implications
American Journal of Reproductive Immunology · 2026-11 · 96 (5)
DOI: 10.1111/aji.70353 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 21.11.2026. Verfasst von Abbas Dehghanian und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Polyendocrine metabolic syndrome (PMOS), previously and widely referred to as polycystic ovary syndrome (PCOS), is a common reproductive and metabolic disorder characterized by hyperandrogenism, mitochondrial dysfunction, and chronic low‐grade inflammation. The cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS–STING) pathway may link mitochondrial injury to inflammatory responses in PCOS. We systematically searched PubMed/MEDLINE, Scopus, and Web of Science from inception to August 21, 2026, for studies investigating STING or the cGAS–STING pathway in women with PCOS or experimental PCOS models. Five studies published between 2021 and 2026 met the inclusion criteria. Human evidence demonstrated increased endometrial STING protein abundance in women with PCOS, while experimental studies consistently implicated mitochondrial DNA (mtDNA) leakage and cGAS–STING activation in PCOS‐associated inflammation. Hyperandrogenism‐induced mitochondrial injury and permeability transition pore opening promoted mtDNA release, STING activation, granulosa‐cell inflammation and apoptosis, and follicular dysfunction. Additional upstream mechanisms included gut microbiota‐associated metabolic disruption and lead‐induced SOD2 dysfunction. STING inhibition or knockout and interventions targeting mitochondrial homeostasis, including ketogenic diet, β‐hydroxybutyrate, 3‐hydroxyanthranilic acid, and SOD2 enhancement, attenuated inflammatory or PCOS‐like phenotypes. Overall, STING may represent a molecular link between mitochondrial damage and inflammation in PCOS, although predominantly preclinical evidence warrants further clinical investigation.
Zitieren
APA
Dehghanian, A., Jahromi, A. R., Jahromi, H. S., & Rahimipour, M. (2026). The Role of the cGAS–STING Pathway in Polycystic Ovary Syndrome: A Systematic Review of Molecular Mechanisms and Therapeutic Implications. American Journal of Reproductive Immunology, 96(5). https://doi.org/10.1111/aji.70353
Vancouver
Dehghanian A, Jahromi AR, Jahromi HS, Rahimipour M. The Role of the cGAS–STING Pathway in Polycystic Ovary Syndrome: A Systematic Review of Molecular Mechanisms and Therapeutic Implications. American Journal of Reproductive Immunology. 2026;96(5). doi:10.1111/aji.70353
BibTeX
@article{Dehghanian2026,
author = {Dehghanian, Abbas and Jahromi, Athar Rasekh and Jahromi, Hossein Safavi and Rahimipour, Marzieh},
title = {The Role of the cGAS–STING Pathway in Polycystic Ovary Syndrome: A Systematic Review of Molecular Mechanisms and Therapeutic Implications},
journal = {American Journal of Reproductive Immunology},
year = {2026},
volume = {96},
number = {5},
doi = {10.1111/aji.70353}
}
EUVIMED